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Introduction
Extrastructurally abnormal chromosomes (ESACs) are
a heterogeneous group. They have been described vari-
ously as markers, supernumeraries, accessories, and 
B-chromosomes.1 Some are harmless and are associated
with phenotypic normality (the B-chromosome), but
others may pose a risk for the fetus. ESACs are encoun-
tered in about 1 in 1,000 prenatal diagnoses, frequently
in the mosaic state with a normal cell line.1–5 More than
50% of ESACs are acrocentric in origin, and idic(15),
commonly referred to as inv dup(15), is the most
common type.4 Owing to their diverse origin and vari-
able euchromatin content, the phenotypes associated
with ESACs vary significantly. This variability poses a
great dilemma for genetic counselors when an ESAC
is detected during prenatal diagnosis because predic-
tion of the pregnancy outcome is difficult. Warburton
reported 123 occurrences of prenatally diagnosed ESAC
cases and estimated that the phenotypic risk associ-
ated with acrocentric origin was 10.9% and that with
nonacrocentric origin was 14.7%.6 Recently, the con-
tribution of molecular cytogenetic analyses (e.g. fluo-
rescence in situ hybridization [FISH] and spectral
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karyotyping [SKY]) have offered the possibility of
rapid identification of the origin and nature of ESACs,
which improves the prediction of clinical outcome
during prenatal genetic counseling.
In this study, we retrospectively reviewed cases of
ESACs detected prenatally in our institution between
January 1983 and March 2008, and attempted to
evaluate the clinical association of the ESACs with
clinical outcomes based on the cytogenetic character-
istics of the ESACs. A review of the relevant literature
was also done.
Methods
We retrospectively checked all cases who received am-
niocentesis and reviewed the 12 ESAC cases we found
in Taichung Veterans General Hospital during the pe-
riod between January 1983 and March 2008.
In situ amniotic fluid cell culture, harvest, and
Giemsa-banding technique were performed accord-
ing to the standard protocols. Twenty primary colonies
were examined by standard analyses. If the available
number of the colonies was fewer than 20, a total of
20 cells from both primary and trypsinized cultures
were examined. True mosaicism was defined as ab-
normal cell lines with ESACs present in at least 2
independent cultures. Special stains, including C- and
NOR-bands, were applied to each ESAC case. Addi-
tional studies performed with the fluorescent dye
DPAI (4’,6-diamidino-2-phenylindole) and SRY gene
(sex-determining region on the Y chromosome) were
individualized. Parents’ karyotypes were determined
in order to identify de novo or familial inheritance 
of the ESACs. In comparison with the long arm of
chromosome 21 (21q), the ESACs were categorized
as small (< 1/2 21q), medium, or large (> 21q).
FISH and/or SKY were performed in 2 recent cases
(nos. 10 and 12 in Table 1) according to the manu-
facturer’s protocol. For case 10 undergoing FISH, 2
centromeric probes (D15Z1, Vysis, Des Plaines, IL,
USA; and D15Z4, Cytocell, Cambridge, UK) and
probes for the Prader-Willi syndrome (SNRPN, Vysis)
and Angelman syndrome (UBE3A, Cytocell) chromo-
some regions were adopted. For case 12, multicolor
SKY paint and FISH with chromosome-specific alphoid
satellite DNA probe for chromosome 10 (CEP10,
Gael, Scotland, UK) were done.
Prenatal ultrasound findings were reviewed in all
cases. Continuous follow-up was conducted for clini-
cal data regarding pregnancy outcome. Before a decision
was made to terminate or continue with the pregnancy,
formal counseling was provided by a genetic counselor.
Results
The prenatal diagnoses of the 12 ESAC cases are
summarized in Table 1. The prenatal prevalence of
ESACs was 0.092% (12/12,991). These cases com-
prised 3.17% (12/378) of all chromosomal disorders
during the study period. The indications for genetic
amniocentesis were advanced maternal age (8/12),
fetal anomaly (2/12), parents’ anxiety (1/12), and
maternal serum test showing high-risk result (1/12).
All 12 ESAC cases were de novo.
Conventional cytogenetics with G-banding tech-
nique showed true mosaicism of ESACs (47,N, +mar/
46,N) in 8/12 cases (66.7%). The size of the ESACs
in 6/12 cases (50%) was large; however, the other 6
(50%) were medium to small. Seven of the 12 ESACs
(58.3%) originated from nonacrocentric chromosomes
and the other 5 (41.7%) were derived from acrocen-
tric chromosomes (D/G groups), with 3 originating
from chromosome 15. The C- and NOR-banding stud-
ies revealed that all acrocentric ESACs contained
dicentric and bisatellite characteristics. FISH results
showed that case 10 originated from chromosome
15. The presence of signals for the Prader-Willi/
Angelman syndrome critical regions (SNRPN and
UBE3A) was confirmed (Figure 1). SKY identified the
ESAC in case 12 as originating from chromosome 10
(Figure 2).
Five of the 12 ESAC cases (41.7%) had congenital
anomalies found by prenatal ultrasound. All of them
were from nonacrocentric chromosomes, including
4/5 (80%) with large (cases 2, 4, 6, and 11) and 1/5
(20%) with medium (case 7) ESACs.
Four of the 12 (33.3%) babies were delivered at
term normally. They were followed-up, with normal
development ranging from 2 to 17 years. After pre-
natal genetic counseling, 8 of the 12 (66.7%) couples
decided to terminate the pregnancy. Of the preg-
nancies that were terminated, 5 fetuses (cases 2, 4, 6,
7 and 11) had apparent congenital abnormalities found
by prenatal ultrasound, 2 (cases 2 and 10) had large-
sized ESACs, and 1 (case 9) had 2 different ESACs.
There were no gross abnormalities found in the 3 ter-
minated fetuses with unremarkable prenatal sonographic
findings. Postnatal investigations using abortus skin
tissues and/or umbilical cord blood confirmed the
prenatal diagnoses in all 8 terminated cases.
Discussion
The origin and genetic content (euchromatin or het-
erochromatin) of ESACs should be investigated.
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Traditionally, this requires the use of special stains,
including C-bands for constitutive heterochromatin
around the centromere and the distal end of the Y chro-
mosome, NOR-bands for the nucleolus organizing
region in the short arms of the acrocentric group
(chromosomes 13, 14, 15, 21 and 22), and DAPI 
for the heterochromatin of chromosomes 9, 15 and 
Y differentially. Through these studies, we identified
5 acrocentric (dicentric and bisatellite) and 7 non-
acrocentric (nonsatellite) ESACs. The origin of 3 acro-
centric ESACs from chromosome 15 was confirmed
due to the presence of positive DAPI stain (cases 1, 3,
and 10); however, the presence of critical regions 
in these cases cannot be excluded without further
evaluations.
With the increasing sophistication of molecular cyto-
genetics (e.g. FISH and SKY), further precise charac-
terization of ESACs is possible. Therefore, it has become
easier to predict the phenotype-genotype correlations
of ESACs. In FISH, about 80% are shown to be derived
from the acrocentric chromosomes, most commonly
from chromosomes 15 or 22, and often involve only
the pericentromeric region and the satellites.7 The
SKY technique offers the possibility of rapid identifi-
cation of the origin and nature of some ESACs.5 In
our study, 2 ESAC cases were investigated further with
FISH (case 10) and SKY (case 12). The presence of
critical regions (SNRPN+ and UBE3A+) for Prader-
Willi/Angelman syndromes in chromosome 15 was
confirmed by FISH in case 10. The pregnancy was
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Figure 1. Serial studies of case 10. (A) Partial karyotype of the fetus with G-, C- (dicentric) and Ag-Nor banding (bisatellite). Metaphase
FISH studies demonstrate the presence of signals for: (B) Prader-Willi syndrome critical region (SNRPN); (C) Angelman syndrome critical
region (UBE3A) of chromosome 15. ESAC = extrastructurally abnormal chromosome.
10 10 ESAC
G C
B
A
Figure 2. Serial studies of case 12. (A) Partial karyotype of the
fetus with G- and C-banding. C-banding discloses that the majority
of this extra material is comprised of constitutive heterochromatin.
(B) The SKY technique confirms chromosome 10 to be the origin.
ESAC = extrastructurally abnormal chromosome.
therefore terminated. The application of SKY in case
12 showed the origin of ESAC to be chromosome
10. The pregnancy continued to term because this
ESAC was small and almost completely comprised 
of C-band-positive heterochromatic materials. With
new modalities to supplant classical cytogenetics, such
as array-CGH and chromosome specific-molecular
rulers, it will be possible to fully characterize the
genetic content and dosage of each ESAC and to
potentially describe/predict the clinical phenotype
for specific cases.8 Replication banding is used primar-
ily to identify inactive X chromatin.5 Therefore, this
technique could be used in a case of ESAC originat-
ing from the X chromosome to further predict the
phenotype.
The unconfirmed origins of the other 8 ESACs in
this study were investigated by conventional G-, C-, and
NOR-banding techniques. Most of them occurred
before the feasibility of FISH or SKY. Some hints
were still present. Two acrocentric ESACs (cases 2
and 5) were expressed by negative DAPI stains, hence
chromosome 15 was excluded as the origin. The other
ESACs may have originated from chromosomes 9p,
16p, X or Y. Nevertheless, conventional techniques
could help provide a basis for further investigations
with molecular studies. This would effectively shorten
the interval between prenatal diagnosis and genetic
counseling.
Upon the discovery of an ESAC at prenatal diag-
nosis, parental chromosomes are required. In prin-
ciple, a heterochromatic ESAC conveys a low risk,
whereas an euchromatic ESAC may imply a high risk
for phenotypic abnormality.6 Given the wide range of
cytogenetic heterogeneity, it is not surprising that
there should be a wide phenotypic range, including
normality.5 The majority of harmless ESACs comprise
acrocentric short arm and pericentromeric material or
other autosomal pericentromeric chromatin.9 Many
ESACs are very small and prone to loss during cell
division, which results in familial mosaicism.10 When
a parent has the ESAC in mosaic state, prediction for
the fetus is more difficult. The chromosome could
potentially be harmful, but the parent might be pro-
tected by a particular tissue distribution.11 Mosaicism
appears not to alter the risk of abnormality. Further-
more, those in whom fetal ultrasonographic anomaly
has been detected are at high risk.
With cytogenetic characterization and prenatal
ultrasound examination, it is possible to precisely cat-
egorize most fetuses with ESACs as being either at
high risk of abnormality or at a relatively low risk. 
The information can be clearly conveyed to the par-
ents of affected fetuses by genetic counselors.
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